FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

36516003: Mepyramine maleate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
60951016 Pyrilamine maleate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2620686017 Mepyramine maleate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3482803016 Mepyramine maleate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
823861000172116 maléate de mépyramine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
50017181000188119 maléate de pyrilamine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mepyramine maleate Is a Pyrilamine false Inferred relationship Some
Mepyramine maleate Is a Sedating antihistamine false Inferred relationship Some
Mepyramine maleate Is a Mepyramine false Inferred relationship Some
Mepyramine maleate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Histamine receptor antagonist (disposition) true Inferred relationship Some
Mepyramine maleate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Mepyramine true Inferred relationship Some
Mepyramine maleate Is a Ethanolamine derivative antihistamine true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mepyramine maleate Inferred relationship Some
pyrilamine maleate+benzocaine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mepyramine maleate Inferred relationship Some
Product containing precisely mepyramine maleate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mepyramine maleate Inferred relationship Some
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Mepyramine maleate Inferred relationship Some 3
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mepyramine maleate Inferred relationship Some 1
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Mepyramine maleate Inferred relationship Some 1
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Mepyramine maleate Inferred relationship Some 3
Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Mepyramine maleate Inferred relationship Some 1
Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Mepyramine maleate Inferred relationship Some 1
Product containing precisely mepyramine maleate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Mepyramine maleate Inferred relationship Some 1
Product containing precisely mepyramine maleate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Mepyramine maleate Inferred relationship Some 1
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Mepyramine maleate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start